Simon Sauve

Health Products And Food Branch
Ottawa, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Durability of DNA-LNP and mRNA-LNP vaccine-induced immunity against SARS-CoV-2 XBB.1.5.

Durability of DNA-LNP and mRNA-LNP vaccine-induced immunity against SARS-CoV-2 XBB.1.5.

Journal: NPJ vaccines
Published: October 15, 2025

Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses.

Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses.

Journal: Antiviral research
Published: August 05, 2025

Polyvalent mRNA vaccine targeting outer surface protein C affords multi-strain protection against Lyme disease.

Polyvalent mRNA vaccine targeting outer surface protein C affords multi-strain protection against Lyme disease.

Journal: NPJ vaccines
Published: July 15, 2025

Advancing Reversed-Phase Chromatography Analytics of Influenza Vaccines Using Machine Learning Approaches on a Diverse Range of Antigens and Formulations.

Advancing Reversed-Phase Chromatography Analytics of Influenza Vaccines Using Machine Learning Approaches on a Diverse Range of Antigens and Formulations.

Journal: Vaccines
Published: June 24, 2025

Borrelia burgdorferi Strain-Specific Differences in Mouse Infectivity and Pathology.

Borrelia burgdorferi Strain-Specific Differences in Mouse Infectivity and Pathology.

Journal: Pathogens (Basel, Switzerland)
Published: March 07, 2025

Erratum: Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters.

Erratum: Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters.

Journal: Molecular therapy. Methods & clinical development
Published: January 06, 2025

Mucosal SARS-CoV-2 S1 adenovirus-based vaccine elicits robust systemic and mucosal immunity and protects against disease in animals.

Mucosal SARS-CoV-2 S1 adenovirus-based vaccine elicits robust systemic and mucosal immunity and protects against disease in animals.

Journal: mBio
Published: December 04, 2024

Dissecting immunological mechanisms underlying influenza viral nucleoprotein-induced mucosal immunity against diverse viral strains.

Dissecting immunological mechanisms underlying influenza viral nucleoprotein-induced mucosal immunity against diverse viral strains.

Journal: Emerging microbes & infections
Published: November 07, 2024

Novel recombinant vaccinia virus-vectored vaccine affords complete protection against homologous Borrelia burgdorferi infection in mice.

Novel recombinant vaccinia virus-vectored vaccine affords complete protection against homologous Borrelia burgdorferi infection in mice.

Journal: Emerging microbes & infections
Published: September 02, 2024

Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters.

Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters.

Journal: Molecular therapy. Methods & clinical development
Published: March 21, 2024

The Expression Kinetics and Immunogenicity of Lipid Nanoparticles Delivering Plasmid DNA and mRNA in Mice.

The Expression Kinetics and Immunogenicity of Lipid Nanoparticles Delivering Plasmid DNA and mRNA in Mice.

Journal: Vaccines
Published: July 31, 2023

Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses.

Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses.

Journal: Emerging microbes & infections
Published: March 17, 2023
Showing 1-12 of 31

Last Updated: 09/26/2026